The infectious respiratory disease COVID-19, caused by the novel Coronavirus SARS-CoV-2, is spreading all over the globe with an alarming speed, and has turned into a pandemic ever since its first appearance in December 2019.
The medical diagnosis of COVID-19 is challenging, since its symptoms are highly variable and can range from asymptomatic condition to flu-like or even life-threatening symptoms like respiratory distress.
Therefore, the WHO recommends screening for the COVID-19 virus via nucleic acid amplification tests, such as RT-PCR.
Convergent Technologies now offers a COVID-19 Test Kit for the use with our Convergys® POC RT-PCR Nucleic Acid Detection System.
It puts the WHO endorsed RT-PCR methodology into a convenient and easy-to-use format.
The kit’s pre-filled, single-use cartridges take care of the complete patient sample processing, including RNA extraction, purification and RT-PCR amplification; all within 90 minutes.
Discover Convergent’s Range of Diagnostic Analyzer Systems.
Dear Business Partners!Our offices shall be closed from the 18th December 2023 till the 1st January 2024 on account of Christmas and New Year Holidays.The
In early 2020, Convergent Technologies introduced its Convergys® POC RT-PCR Nucleic Acid Detection System, a fully-integrated system from the viral RNA extraction to onsite reference
Convergent Technologies returns to Germany’s leading international medical trade fair MEDICA in the Düsseldorf Exhibition Center. Visit our booth in Hall 1 / 1D57 to
Convergent Technologies is an emerging leader in the field of Integrated Healthcare Solutions. We strive to provide innovative and cost-effective healthcare solutions enabling people live healthier lives.
Our state of the art diagnostic test and systems concentrate on early detection, targeted screening, evaluation and monitoring of diseases.
Convergent Technologies GmbH & Co. KG
Ringstrasse 14
35091 Coelbe, Germany
Tel: +49 6421 88699-48
Fax: +49 6421 88699-58
© Convergent Technologies. All rights reserved.
